APA Alıntı

OKITA, R., SHIMIZU, K., NOJIMA, Y., YUKAWA, T., MAEDA, A., SAISHO, S., & NAKATA, M. (2015). Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells. Oncol Rep.

Chicago Stili Alıntı

OKITA, RIKI, KATSUHIKO SHIMIZU, YUJI NOJIMA, TAKURO YUKAWA, AI MAEDA, SHINSUKE SAISHO, ve MASAO NAKATA. "Lapatinib Enhances Trastuzumab-mediated Antibody-dependent Cellular Cytotoxicity Via Upregulation of HER2 in Malignant Mesothelioma Cells." Oncol Rep 2015.

MLA Alıntı

OKITA, RIKI, et al. "Lapatinib Enhances Trastuzumab-mediated Antibody-dependent Cellular Cytotoxicity Via Upregulation of HER2 in Malignant Mesothelioma Cells." Oncol Rep 2015.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..